Building Bridges to Innovation 2016

Whitepaper | McKinsey & Co.

Building Bridges to Innovation 2016

Commissioned for the 3rd BioCentury China Healthcare Summit (Oct. 18-19, 2016, Shanghai), this exclusive report discusses the latest trends shaping the biopharma and medtech industries in China.

Based on a survey of industry leaders, the report details:

  • How biopharma business models are changing in China to meet evolving customer needs;
  • China's latest policy initiatives meant to support biopharma innovation;
  • The latest trends impacting patient access to mature and innovative drugs in China;
  • Updated views on McKinsey's annual China Drug Innovation Index (CDII); and
  • Key trends shaping the medtech environment in China.